CN102524422B - 含α-乳白蛋白和乳铁蛋白的婴幼儿配方奶粉及制备方法 - Google Patents
含α-乳白蛋白和乳铁蛋白的婴幼儿配方奶粉及制备方法 Download PDFInfo
- Publication number
- CN102524422B CN102524422B CN201210041279.9A CN201210041279A CN102524422B CN 102524422 B CN102524422 B CN 102524422B CN 201210041279 A CN201210041279 A CN 201210041279A CN 102524422 B CN102524422 B CN 102524422B
- Authority
- CN
- China
- Prior art keywords
- lactoferrin
- milk powder
- ala
- powder
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000843 powder Substances 0.000 title claims abstract description 82
- 235000013350 formula milk Nutrition 0.000 title claims abstract description 63
- 102000010445 Lactoferrin Human genes 0.000 title claims abstract description 57
- 108010063045 Lactoferrin Proteins 0.000 title claims abstract description 57
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 title claims abstract description 57
- 235000021242 lactoferrin Nutrition 0.000 title claims abstract description 57
- 229940078795 lactoferrin Drugs 0.000 title claims abstract description 57
- 235000013336 milk Nutrition 0.000 title claims abstract description 50
- 239000008267 milk Substances 0.000 title claims abstract description 50
- 210000004080 milk Anatomy 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 102000004407 Lactalbumin Human genes 0.000 title abstract description 13
- 108090000942 Lactalbumin Proteins 0.000 title abstract description 13
- 235000021241 α-lactalbumin Nutrition 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 claims abstract description 73
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 32
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 32
- 239000005862 Whey Substances 0.000 claims abstract description 31
- 235000015097 nutrients Nutrition 0.000 claims abstract description 21
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 20
- 239000011707 mineral Substances 0.000 claims abstract description 20
- 235000010755 mineral Nutrition 0.000 claims abstract description 20
- 235000019742 Vitamins premix Nutrition 0.000 claims abstract description 18
- 230000036039 immunity Effects 0.000 claims abstract description 16
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 13
- 230000000694 effects Effects 0.000 claims abstract description 12
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 11
- 239000008158 vegetable oil Substances 0.000 claims abstract description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 10
- 239000008103 glucose Substances 0.000 claims abstract description 10
- 239000007787 solid Substances 0.000 claims abstract description 10
- 235000020357 syrup Nutrition 0.000 claims abstract description 10
- 239000006188 syrup Substances 0.000 claims abstract description 10
- 239000000126 substance Substances 0.000 claims description 17
- 238000002156 mixing Methods 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 12
- 238000012856 packing Methods 0.000 claims description 8
- 235000013305 food Nutrition 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 3
- 235000020256 human milk Nutrition 0.000 abstract description 31
- 210000004251 human milk Anatomy 0.000 abstract description 31
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract description 7
- 239000008101 lactose Substances 0.000 abstract description 7
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 230000001502 supplementing effect Effects 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 229920001542 oligosaccharide Polymers 0.000 abstract 1
- 150000002482 oligosaccharides Chemical class 0.000 abstract 1
- 235000021119 whey protein Nutrition 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 16
- 238000012360 testing method Methods 0.000 description 13
- 239000002131 composite material Substances 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 8
- 235000020247 cow milk Nutrition 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 241000256856 Vespidae Species 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 241000287828 Gallus gallus Species 0.000 description 5
- -1 dry 11.1%) Substances 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 210000003024 peritoneal macrophage Anatomy 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 238000013459 approach Methods 0.000 description 4
- 229960000796 barbital sodium Drugs 0.000 description 4
- FTOAOBMCPZCFFF-UHFFFAOYSA-N barbitone sodium Natural products CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000020610 powder formula Nutrition 0.000 description 4
- 230000004620 sleep latency Effects 0.000 description 4
- RGHFKWPGWBFQLN-UHFFFAOYSA-M sodium;5,5-diethylpyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].CCC1(CC)C([O-])=NC(=O)NC1=O RGHFKWPGWBFQLN-UHFFFAOYSA-M 0.000 description 4
- 230000007306 turnover Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 239000003228 hemolysin Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 108010006464 Hemolysin Proteins Proteins 0.000 description 2
- 235000008452 baby food Nutrition 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 231100000041 toxicology testing Toxicity 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 241000024188 Andala Species 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- 101710126949 Lysin Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 102100033468 Lysozyme C Human genes 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229940127282 angiotensin receptor antagonist Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000008131 children development Effects 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 238000002715 modification method Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000036417 physical growth Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
Images
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
乳清蛋白组成 | 人乳 | 牛乳 |
乳铁蛋白 | 1.70 | 微量 |
α-乳白蛋白 | 2.60 | 1.1 |
β-乳球蛋白 | -- | 3.6 |
血清白蛋白 | 0.5 | 0.4 |
溶菌酶 | 0.5 | 微量 |
免疫球蛋白 | 1.05 | 0.66 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210041279.9A CN102524422B (zh) | 2012-02-22 | 2012-02-22 | 含α-乳白蛋白和乳铁蛋白的婴幼儿配方奶粉及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210041279.9A CN102524422B (zh) | 2012-02-22 | 2012-02-22 | 含α-乳白蛋白和乳铁蛋白的婴幼儿配方奶粉及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102524422A CN102524422A (zh) | 2012-07-04 |
CN102524422B true CN102524422B (zh) | 2014-01-29 |
Family
ID=46333465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210041279.9A Active CN102524422B (zh) | 2012-02-22 | 2012-02-22 | 含α-乳白蛋白和乳铁蛋白的婴幼儿配方奶粉及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102524422B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103371235B (zh) * | 2012-04-24 | 2019-03-08 | 杭州千岛湖康诺邦健康产品有限公司 | 一种婴幼儿配方奶粉及其制备方法 |
MX369440B (es) * | 2012-10-03 | 2019-11-08 | Univ Illinois | Modulación de la función inmunitaria por lactoferrina de bovinos en la dieta. |
CN103636792B (zh) * | 2013-12-02 | 2016-05-25 | 光明乳业股份有限公司 | 营养奶粉 |
CA2984869C (en) | 2015-05-04 | 2023-08-15 | Enzymotec Ltd. | Lipid compositions for improving sleep |
US11197917B2 (en) * | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
CN108294112B (zh) * | 2018-01-12 | 2021-08-06 | 雅士利国际婴幼儿营养品有限公司 | 优化蛋白质和氨基酸模式的婴儿配方奶粉及其制备方法 |
US20220072107A1 (en) * | 2018-12-21 | 2022-03-10 | Societe Des Produits Nestle S.A. | Nutritional composition for inducing a feeling of satiety, a better sleep and/or limiting nocturnal awaking in infants or young children |
CN112042750B (zh) * | 2020-09-09 | 2022-04-05 | 北京三元食品股份有限公司 | 一种富含乳脂肪球膜蛋白、磷脂和低聚糖的婴幼儿配方奶粉及其制备方法 |
CN112244093A (zh) * | 2020-10-20 | 2021-01-22 | 应荣科 | 含IgG、α-乳白蛋白和乳铁蛋白的调制乳粉及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101248816A (zh) * | 2008-03-28 | 2008-08-27 | 新希望乳业控股有限公司 | 一种低乳糖巴氏杀菌奶及制备方法 |
CN101341908A (zh) * | 2007-05-28 | 2009-01-14 | 昆明雪兰牛奶有限责任公司 | 高蛋白牛奶 |
CN101984836A (zh) * | 2010-09-06 | 2011-03-16 | 浙江贝因美科工贸股份有限公司 | 一种新型婴幼儿配方奶粉的生产方法 |
CN102283289A (zh) * | 2011-09-15 | 2011-12-21 | 澳优乳业(中国)有限公司 | 一种不上火的婴幼儿配方奶粉及其制备工艺 |
-
2012
- 2012-02-22 CN CN201210041279.9A patent/CN102524422B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101341908A (zh) * | 2007-05-28 | 2009-01-14 | 昆明雪兰牛奶有限责任公司 | 高蛋白牛奶 |
CN101248816A (zh) * | 2008-03-28 | 2008-08-27 | 新希望乳业控股有限公司 | 一种低乳糖巴氏杀菌奶及制备方法 |
CN101984836A (zh) * | 2010-09-06 | 2011-03-16 | 浙江贝因美科工贸股份有限公司 | 一种新型婴幼儿配方奶粉的生产方法 |
CN102283289A (zh) * | 2011-09-15 | 2011-12-21 | 澳优乳业(中国)有限公司 | 一种不上火的婴幼儿配方奶粉及其制备工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN102524422A (zh) | 2012-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102524422B (zh) | 含α-乳白蛋白和乳铁蛋白的婴幼儿配方奶粉及制备方法 | |
CN104642735B (zh) | 一种饲料用复合糖制剂及含其饲料和应用 | |
CN102511720B (zh) | 一种水苏糖婴幼儿营养米粉和其制备方法 | |
CN102318785B (zh) | 具有提高出生重和泌乳量的母猪饲料添加剂及其生产方法 | |
CN103181496B (zh) | 一种仔猪奶粉 | |
CN104186948A (zh) | 一种全效保健的猪浓缩料 | |
CN102940160B (zh) | 一种促进雏鸡消化道发育的幼禽配合饲料及其制备方法 | |
CN103330059B (zh) | 一种兽用保健组合物及其制备方法和用途 | |
CN101703170A (zh) | 一种家禽饲料及其制备方法 | |
CN107149046A (zh) | 功能性复合膳食纤维、制备方法及应用 | |
CN103349164A (zh) | 一种乌鸡雏鸡中草药饲料添加剂 | |
CN107183372B (zh) | 一种用于肉用犊牛断奶的代乳料 | |
CN107373130A (zh) | 一种缓解仔猪断奶应激的替抗饲料添加剂 | |
CN106889327A (zh) | 一种乳猪奶粉及其制备方法 | |
CN111587923A (zh) | 一种含有唾液酸的婴儿配方食品及制备方法 | |
CN106721305A (zh) | 一种能改善母猪分娩后体况或其生产性能的添加剂组合物及其制备方法 | |
CN112293578A (zh) | 一种宠物用的免疫复合物 | |
CN111919889A (zh) | 一种提高免疫力的母乳化婴幼儿配方羊奶粉及其制备方法 | |
CN105941890A (zh) | 预防育肥绵羊黄脂膘的精料补充饲料 | |
CN104642733B (zh) | 一种饲料用复合糖制剂、含其饲料添加剂及饲料和应用 | |
CN111631305B (zh) | 一种用于提高母羊生产、改善羔羊生长性能的饲料添加剂 | |
CN104920809A (zh) | 一种改善母猪奶水的饲料添加剂预混剂及其使用方法 | |
CN104642732A (zh) | 一种肉鸭饲料添加剂及其应用 | |
CN106234795A (zh) | 一种用于病猪康复或幼龄猪只的健康营养补剂 | |
CN106071129A (zh) | 一种可促消化调理肠胃的兔饲料配方及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: ZHEJIANG KANGNUOBANG HEALTH PRODUCTS CO., LTD. Free format text: FORMER NAME: ZHEJIANG CONBA HEALTH PRODUCTS CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 310052 Binjiang District, Zhejiang Province, Hangzhou Road, No. 568 Patentee after: ZHEJIANG CANOBANK HEALTH PRODUCT Co.,Ltd. Address before: 310052 Binjiang District, Zhejiang Province, Hangzhou Road, No. 568 Patentee before: ZHEJIANG CONBA HEALTH PRODUCT Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Infant formula milk powder containing alpha-lactalbumin and lactoferrin and preparation method for infant formula milk powder Effective date of registration: 20150906 Granted publication date: 20140129 Pledgee: Hangzhou hi tech Company limited by guarantee Pledgor: ZHEJIANG CANOBANK HEALTH PRODUCT Co.,Ltd. Registration number: 2015330000043 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20160707 Granted publication date: 20140129 Pledgee: Hangzhou hi tech Company limited by guarantee Pledgor: ZHEJIANG CANOBANK HEALTH PRODUCT Co.,Ltd. Registration number: 2015330000043 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Infant formula milk powder containing alpha-lactalbumin and lactoferrin and preparation method for infant formula milk powder Effective date of registration: 20160714 Granted publication date: 20140129 Pledgee: Hangzhou hi tech Company limited by guarantee Pledgor: ZHEJIANG CANOBANK HEALTH PRODUCT Co.,Ltd. Registration number: 2016330000032 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20170613 Granted publication date: 20140129 Pledgee: Hangzhou hi tech Company limited by guarantee Pledgor: ZHEJIANG CANOBANK HEALTH PRODUCT Co.,Ltd. Registration number: 2016330000032 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Infant formula milk powder containing alpha-lactalbumin and lactoferrin and preparation method for infant formula milk powder Effective date of registration: 20170615 Granted publication date: 20140129 Pledgee: Hangzhou hi tech Company limited by guarantee Pledgor: ZHEJIANG CANOBANK HEALTH PRODUCT Co.,Ltd. Registration number: 2017330000054 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230808 Address after: 311700 No.7, Park Avenue, ecological industrial park, Qiandaohu High Speed Railway New District, Chun'an County, Hangzhou City, Zhejiang Province Patentee after: HANGZHOU QIANDAOHU CANOBANK HEALTH PRODUCT CO.,LTD. Address before: 310052 No. 568, bin Kang Road, Hangzhou, Zhejiang, Binjiang District Patentee before: ZHEJIANG CANOBANK HEALTH PRODUCT Co.,Ltd. |
|
TR01 | Transfer of patent right |